|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-3-14
|
|
pubmed:abstractText |
To compare the efficacy and tolerability of felodipine extended release (ER) 2.5 mg (F2.5) and 5 mg (F5) once daily with nifedipine Retard 10 mg (N20) and 20 mg (N40) twice daily as additional therapy in patients who remained hypertensive despite treatment with an ACE-inhibitor, beta-blocker or diuretic.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0300-2977
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2-12
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9038037-Adult,
pubmed-meshheading:9038037-Aged,
pubmed-meshheading:9038037-Blood Pressure,
pubmed-meshheading:9038037-Blood Pressure Monitoring, Ambulatory,
pubmed-meshheading:9038037-Calcium Channel Blockers,
pubmed-meshheading:9038037-Double-Blind Method,
pubmed-meshheading:9038037-Drug Tolerance,
pubmed-meshheading:9038037-Felodipine,
pubmed-meshheading:9038037-Female,
pubmed-meshheading:9038037-Follow-Up Studies,
pubmed-meshheading:9038037-Humans,
pubmed-meshheading:9038037-Hypertension,
pubmed-meshheading:9038037-Male,
pubmed-meshheading:9038037-Middle Aged,
pubmed-meshheading:9038037-Nifedipine,
pubmed-meshheading:9038037-Treatment Outcome
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Calcium antagonists, a useful additional therapy in treatment resistant hypertension: comparison of felodipine ER and nifedipine Retard by 24-h ambulatory blood pressure monitoring.
|
|
pubmed:affiliation |
Department of Internal Medicine, Ikazia Ziekenhuis, Rotterdam, Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
